Response, Resistance, Metastasis

Meta-analysis of the effect of p-glycoprotein expression on outcome in AML

JA Holmes, RR West

Soluble and cellular interleukin-2 receptors : correlation with clinical response in metastatic malignant melanoma (MMM) patients treated by chemoimmunotherapy

Cl Soubrane, R Mouawad, 0 Rixe, Ch Bore], A Benhammouda, M Well, D Khayat

TGF-beta(1) expression modulates drug resistance and gene amplification potential

A Huang, H Jin and JA Wright

Flow cytometric assay of resistance to intravesical epirubicin

P Duffy, A Cooper

Detection of urokinase-type plasminogen activator, its receptor and type 1 inhibitor mRNAs in giant cell tumours of bone

DJ Wood, Y Fan, SJ Wysocki, M Beilharz, JM Papadimitriou & MH Zheng

Beta4 integrin subunit expression is down-regulated in low metastatic carcinoma variants

L Cimino, D Perrotti, R Falcioni, G D'Agostino, A Sacchi

Serum basement membrane fragments, hyaluronate, prolyl hydroxylase, and ICAM-1 in small cell lung cancer: indicators of distant metastasis?

M Miyake, T Nakano, M Shinjo, T Nishian, T Nakae, H Togawa, K Ninomiya, T Hada, K Higashino

Expression of 0(6)-methylguanine-DNA methyltransferase in human tumors

I Preuss, I Eberhagen, S Haas, RH Eibl,M Kaufmann, T Beck, W Dippold, and B Kaina

Detoxification of cyclophosphamide by aldehyde dehydrogenases

DP Agarwal, D Meier-Tackmann, U von Eitzen, HW Goedde

No relation between mr 111.000 vesicular protein and multidrug resistance in acute leukemia

B Drenou, L Amiot, T Lamy, I Grulois, PY Le Prise, R Fauchet

Expression of the MDR3 gene and its product in malignant hematopoietic cells

M Masuda, Y Arai, I Sugawara, T Arai, T Motoji, H Mizoguchi

Multidrug resistance activity (MDR) determined by rhodamin 123 efflux in hematological malignancies

B Drenou, T Lamy, I Grulois, B Amiot, PY Le Prise', R Fauchet